Products

overview

We are focused on the development of small molecule inhibitors target malignant cells both directly and through modulation of the tumor microenvironment. Our most advanced programs target the phosphoinositide-3-kinase (PI3K) and Focal Adhesion Kinase (FAK) pathways.

Verastem product pipeline